Arkolith/Insider Trading/KRRO/Form 4

Agarwal Vineet

Chief Financial OfficerKorro Bio, Inc. (KRRO) · full profile →Form 4 · filed Nov 12, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$56K
Net Open-Market Flow
-$56K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 11, 2024Sell(S)800$70.00$56K0
Nov 11, 2024Option exercise(M)800$11.68$9K800

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 11, 2024Option exercise(M)800—$031K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-125822) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Korro Bio, Inc.

Build

Ask your agent about KRRO insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000950170-24-125822"
Ask your agent
Use Arkolith to summarize insider buying and selling at Korro Bio, Inc.
over the last 90 days and cite the filings.